Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Niklas Schäfer(University of Bonn), Martin Glas(University of Bonn), Christoph Kleinschnitz, Pitt Niehusmann(Oslo University Hospital), Matthias Simon(University of Bonn), Sied Kebir(University of Bonn), Roman Reinartz(University of Bonn), Torsten Pietsch(University of Bonn), Björn Scheffler(German Cancer Research Center), Ulrich Herrlinger(University of Bonn), Laurèl Rauschenbach(University of Bonn), Andreas Till(University of Bonn), Gerrit H. Gielen(St Nicholas Hospital)
Cited by 78
Related Papers
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Animal models of ischemic stroke and their application in clinical research
|Drug Design Development and Therapy|2015|639
Multipotent Stem/Progenitor Cells with Similar Properties Arise from Two Neurogenic Regions of Adult Human Brain
|Experimental Neurology|1999|523
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
|The Journal of Experimental Medicine|2006|447